
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
2025-05-05
0:00
21:13
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
Fler avsnitt från "JAMA Neurology Author Interviews"



Missa inte ett avsnitt av “JAMA Neurology Author Interviews” och prenumerera på det i GetPodcast-appen.







